Hoth Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q2 2024 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q3 2024 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q1 2025 | 1 | -$0.25 | -$0.25 | -$0.25 |
| Q2 2025 | 1 | -$0.25 | -$0.25 | -$0.25 |
| Q3 2025 | 1 | -$0.22 | -$0.22 | -$0.22 |
| Q4 2025 | 1 | -$0.17 | -$0.17 | -$0.17 |
Hoth Therapeutics, Inc. Earnings Date And Information
Hoth Therapeutics, Inc. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-0.31 earnings per share for the quarter, missing analysts' consensus estimates of $-0.3 by $0.01. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Hoth Therapeutics, Inc. has generated $-2 earnings per share over the last year ($-2.3 diluted earnings per share) and currently has a price-to-earnings ratio of -1.07. Hoth Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Hoth Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.30 | $0.00 | $0 | $0 | |
| 08/09/2024 | Q2 2024 | -$0.39 | -$0.24 | 0.15 | $0 | $0 |
| 05/14/2024 | Q1 2024 | -$0.43 | -$0.46 | -0.03 | $0 | |
| 03/28/2024 | Q4 2023 | -$0.39 | $59,538 | |||
| 11/13/2023 | Q3 2023 | -$0.72 | -$0.60 | 0.12 | $0 | |
| 08/11/2023 | Q2 2023 | -$1.16 | -$0.57 | 0.59 | $0 | |
| 05/15/2023 | Q1 2023 | $0.86 | -$0.88 | -1.74 | $0 | |
| 03/31/2023 | Q4 2022 | -$3.19 | $0 | |||
| 11/10/2022 | Q3 2022 | -$2.39 | -$2.02 | 0.37 | $0 | |
| 08/12/2022 | Q2 2022 | -$2.25 | -$2.16 | 0.09 | $0 | |
| 05/12/2022 | Q1 2022 | -$3.00 | -$2.59 | 0.41 | $0 | |
| 03/29/2022 | Q4 2021 | -$3.90 | $0 | |||
| 11/10/2021 | Q3 2021 | -$3.75 | -$3.45 | 0.3 | $0 | |
| 08/11/2021 | Q2 2021 | -$4.50 | -$3.46 | 1.04 | $0 | |
| 05/13/2021 | Q1 2021 | -$2.50 | -$6.03 | -3.53 | $0 | |
| 03/16/2021 | Q4 2020 | -$1.53 | $0 | |||
| 11/10/2020 | Q3 2020 | -$3.25 | -$3.94 | -0.69 | $0 | |
| 08/13/2020 | Q2 2020 | -$3.50 | -$5.07 | -1.57 | $0 | |
| 05/13/2020 | Q1 2020 | -$4.25 | -$4.45 | -0.2 | $0 | |
| 03/02/2020 | Q4 2019 | -$10.67 | $0 |
Hoth Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Hoth Therapeutics, Inc.'s earnings date?
Hoth Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
-
How can I listen to Hoth Therapeutics, Inc.'s earnings conference call?
The conference call for Hoth Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Hoth Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Hoth Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Hoth Therapeutics, Inc. generate each year?
Hoth Therapeutics, Inc. (:HOTH) has a recorded net income of $0. Hoth Therapeutics, Inc. has generated $-2.3 earnings per share over the last four quarters.
-
What is Hoth Therapeutics, Inc.'s price-to-earnings ratio?
Hoth Therapeutics, Inc. (:HOTH) has a price-to-earnings ratio of -1.07 and price/earnings-to-growth ratio is -0.03.
